Singapore markets open in 6 hours 32 minutes

Evofem Biosciences, Inc. (EVFM)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0136+0.0007 (+5.20%)
As of 02:07PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
50,524
52,979
-76,698
-205,192
-142,309
-
Depreciation & amortisation
1,091
1,781
2,046
1,023
302
-
Stock-based compensation
1,009
1,189
3,313
8,898
12,697
-
Change in working capital
10,231
4,728
6,018
10,578
-15,227
-
Accounts receivable
3,098
-4,612
5,323
-5,382
-1,067
-
Inventory
2,596
2,106
1,566
-21
-6,010
-
Accounts payable
-449
4,090
4,474
-4
4,126
-
Other working capital
-3,920
-8,972
-70,751
-149,606
-107,083
-
Other non-cash items
1,803
1,804
3,243
4,069
2,940
-
Net cash provided by operating activities
-3,905
-8,968
-70,410
-146,667
-104,829
-
Cash flows from investing activities
Investments in property, plant and equipment
-15
-4
-341
-2,939
-2,254
-
Purchases of investments
-
-
-
-
0
-8,233
Sales/maturities of investments
-
-
0
0
8,233
0
Net cash used for investing activities
-15
-4
-341
-2,689
6,229
-
Cash flows from financing activities
Debt repayment
-
-1,154
-5,892
0
0
-
Common stock issued
-
0
32,320
81,534
107,519
-
Common stock repurchased
-
0
-18
0
-
-
Dividends paid
-
-
-
-
-
0
Other financing activities
-
-
-1,202
-1,297
-3,742
-2,852
Net cash used provided by (used for) financing activities
3,075
4,776
61,939
90,693
154,226
-
Net change in cash
-845
-4,196
-8,812
-58,663
55,626
-
Cash at beginning of period
1,534
4,776
13,588
72,251
16,625
-
Cash at end of period
689
580
4,776
13,588
72,251
-
Free cash flow
Operating cash flow
-3,905
-8,968
-70,410
-146,667
-104,829
-
Capital expenditure
-15
-4
-341
-2,939
-2,254
-
Free cash flow
-3,920
-8,972
-70,751
-149,606
-107,083
-